Phenotypic consensus markers for plasma cell myeloma.
作者信息
Hur Mina
机构信息
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea.
出版信息
Korean J Hematol. 2012 Dec;47(4):239-40. doi: 10.5045/kjh.2012.47.4.239. Epub 2012 Dec 24.
Abstract
摘要
相似文献
1
Phenotypic consensus markers for plasma cell myeloma.
Korean J Hematol. 2012 Dec;47(4):239-40. doi: 10.5045/kjh.2012.47.4.239. Epub 2012 Dec 24.
2
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
Cytometry B Clin Cytom. 2016 Jan;90(1):31-9. doi: 10.1002/cyto.b.21228. Epub 2015 Jun 2.
3
Plasma cell myeloma marrow diagnosis including morphologic and phenotypic features.
Semin Diagn Pathol. 2003 Aug;20(3):211-25. doi: 10.1016/s0740-2570(03)00027-3.
4
[Phenotypic analysis of myeloma cells].
Nihon Rinsho. 1995 Mar;53(3):574-9.
5
Role of F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Lancet Oncol. 2017 Apr;18(4):e206-e217. doi: 10.1016/S1470-2045(17)30189-4.
6
Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics.
Br J Haematol. 1993 Nov;85(3):504-13. doi: 10.1111/j.1365-2141.1993.tb03340.x.
7
Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium.
Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):e352-e367. doi: 10.1016/j.clml.2020.01.017. Epub 2020 Feb 4.
8
Phenotypic difference of normal plasma cells from mature myeloma cells.
Blood. 1993 May 15;81(10):2658-63.
9
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Cytometry B Clin Cytom. 2016 Jan;90(1):61-72. doi: 10.1002/cyto.b.21265. Epub 2015 Jul 31.
10
Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Blood Cells Mol Dis. 2000 Dec;26(6):634-45. doi: 10.1006/bcmd.2000.0342.
本文引用的文献
1
Simplified flow cytometric immunophenotyping panel for multiple myeloma, CD56/CD19/CD138(CD38)/CD45, to differentiate neoplastic myeloma cells from reactive plasma cells.
Korean J Hematol. 2012 Dec;47(4):260-6. doi: 10.5045/kjh.2012.47.4.260. Epub 2012 Dec 24.
2
Role of flow cytometry of peripheral blood and bone marrow aspirates in early myeloma.
Semin Hematol. 2011 Jan;48(1):32-8. doi: 10.1053/j.seminhematol.2010.11.005.
3
Review of phenotypic markers used in flow cytometric analysis of MGUS and MM, and applicability of flow cytometry in other plasma cell disorders.
Br J Haematol. 2010 May;149(3):334-51. doi: 10.1111/j.1365-2141.2010.08121.x. Epub 2010 Mar 1.
4
Phenotype of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
Neoplasma. 2009;56(6):526-32. doi: 10.4149/neo_2009_06_526.
5
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders.
Haematologica. 2008 Mar;93(3):431-8. doi: 10.3324/haematol.11080. Epub 2008 Feb 11.
6
Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Haematologica. 2001 Aug;86(8):837-43.
7
8
Phenotypic difference of normal plasma cells from mature myeloma cells.
Blood. 1993 May 15;81(10):2658-63.
Zotero 插件